Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OFFICE) Study

Inclusion Criteria:

1. The subject has NOSE Score ≥55.

2. The subject has dynamic lateral nasal wall insufficiency as confirmed by Positive
Modified Cottle Maneuver.

3. The subject is ≥18 years of age.

4. The subject is willing and able to provide informed consent and comply with the study
protocol.

5. The subject is seeking treatment for nasal airway obstruction due to Nasal Valve
Collapse (NVC) and is willing to undergo an in-office nasal implant procedure alone or
with a turbinate reduction procedure.

6. The subject has appropriate nasal and facial anatomy to receive the Latera Implant.

7. The subject agrees to follow-up examinations through twelve (12) months post
operatively.

8. The subject has failed to benefit from appropriate maximal medical management [e.g.,
nasal steroids (at least 4 weeks); antihistamines; oral decongestants; nasal strips,
stents, or cones]. Failure of maximal medical management may be from lack of
effectiveness or tolerability.

Exclusion Criteria:

1. The subject is having a concurrent Functional Endoscopic Sinus Surgery (FESS) or
sinuplasty.

2. The subject has had rhinoplasty within the past twelve (12) months.

3. The subject is planning to have other concurrent rhinoplasty procedure.

4. The subject is planning to have other rhinoplasty procedures or will use external
dilators within twelve (12) months after the index procedure.

5. The subject has had septoplasty and/or inferior turbinate reduction within the past
six (6) months.

6. The subject has, in the view of the clinician, inappropriate fixation on their nasal
airway.

7. The subject plans to have any surgical or non-surgical treatment of their nasal valve,
other than the index procedure, within twelve (12) months of the study.

8. The subject has a permanent Implant or dilator in the nasal area.

9. The subject has concomitant inflammatory or infectious skin conditions or unhealed
wounds in the treatment area.

10. The subject currently has active nasal vestibulitis.

11. The subject has a history of nasal vasculitis.

12. The subject is a chronic systemic steroid or recreational intra-nasal drug user.

13. The subject has had a cancerous or pre-cancerous lesion and/or has had radiation
exposure in the treatment area or chemotherapy.

14. The subject has polyps or pathology (i.e., septal deviation) other than turbinate
hypertrophy and/or lateral wall insufficiency that would contribute to airway
obstruction.

15. The subject has a history of a significant bleeding disorder(s) that would prevent
healing of the treatment area post procedure.

16. The subject has a known or suspected allergy to PLA or other absorbable materials.

17. The subject has a significant systemic disease such as poorly controlled diabetes
which, in the investigator's opinion, could pre-dispose the subject to poor wound
healing.

18. The subject is currently using nasal oxygen or CPAP.

19. The subject is not a candidate for procedures conducted under local anesthesia and/or
managed anesthesia care (MAC) or conscious sedation.

20. Female subjects of child bearing potential, known or suspected to be pregnant or is
lactating.